×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CCCC – c4 therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CCCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
04:18 am
cccc
Comprehensive Synovial Sarcoma Pipeline Landscape Report for 2024: In-depth Analysis of 20+ Pipeline Drugs and 15+ Companies [Yahoo! Finance]
Low
Report
Comprehensive Synovial Sarcoma Pipeline Landscape Report for 2024: In-depth Analysis of 20+ Pipeline Drugs and 15+ Companies [Yahoo! Finance]
11/20
07:07 am
cccc
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors [Yahoo! Finance]
Medium
Report
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors [Yahoo! Finance]
11/20
07:00 am
cccc
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
Medium
Report
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
11/18
08:50 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
Medium
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
11/6
07:00 am
cccc
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
Medium
Report
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
11/5
09:00 am
cccc
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
Medium
Report
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
10/31
07:00 am
cccc
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
10/28
04:01 pm
cccc
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/20
07:12 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Nov 20
Medium
Report
Form 8-K C4 Therapeutics, Inc. For: Nov 20
11/18
04:43 pm
cccc
Form 144 C4 Therapeutics, Inc. Filed by: Salter Malcolm
Low
Report
Form 144 C4 Therapeutics, Inc. Filed by: Salter Malcolm
11/15
04:06 pm
cccc
Form 424B3 C4 Therapeutics, Inc.
Low
Report
Form 424B3 C4 Therapeutics, Inc.
11/15
04:06 pm
cccc
Form 424B5 C4 Therapeutics, Inc.
Low
Report
Form 424B5 C4 Therapeutics, Inc.
11/14
07:53 pm
cccc
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Medium
Report
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
11/14
06:44 pm
cccc
Form SC 13G C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SC 13G C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
11/14
04:06 pm
cccc
Form SC 13G/A C4 Therapeutics, Inc. Filed by: COMMODORE CAPITAL LP
Medium
Report
Form SC 13G/A C4 Therapeutics, Inc. Filed by: COMMODORE CAPITAL LP
11/14
03:30 pm
cccc
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Soleus Capital Master Fund, L.P.
Low
Report
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Soleus Capital Master Fund, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: